Triple therapy attack on liver metastases from rectal cancer shows promise
NCT ID NCT06787183
First seen Mar 08, 2026 · Last updated May 21, 2026 · Updated 8 times
Summary
This study tests a new approach for people with rectal cancer that has spread to the liver. It combines short-course radiation, chemotherapy (CAPOX), and an immunotherapy drug (QL1706) that targets two immune checkpoints. The goal is to improve how long the cancer stays under control. About 42 adults aged 18-75 with a specific cancer type (MSS/pMMR) who have not had prior treatment are eligible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED RECTAL CANCER WITH LIVER METASTASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fujian Cancer Hospital
RECRUITINGFuzhou, Fujian, 350014, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
Fuzhou First General Hospital
NOT_YET_RECRUITINGFuzhou, Fujian, 350004, China
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.